Research Disciplines

• Immunology (1107)

Socio-Economic Objectives

• Clinical Health (9201)

These are the most recent publications associated with this author. To see a detailed profile of all publications stored at JCU, visit ResearchOnline@JCU. Hover over Altmetrics badges to see social impact.

Journal Articles

• Cole D, Fuller A, Dolton G, Zervoudi E, Legut M, Miles K, Blanchfield L, Madura F, Holland C, Bulek A, Bridgeman J, Miles J, Schauenburg A, Beck K, Evavold B, Rizkallah P and Sewell A (2017) Dual molecular mechanisms govern escape at immunodominant HLA A2-restricted HIV epitope. Frontiers in Immunology, 8.
• Cole D, Van Den Berg H, Lloyd A, Crowther M, Beck K, Ekeruche-Makinde J, Miles J, Bulek A, Dolton G, Schauenburg A, Wall A, Fuller A, Clement M, Laugel B, Rizkallah P, Wooldridge L and Sewell A (2017) Structural mechanism underpinning cross-reactivity of a CD8(+) T-cell clone that recognizes a peptide derived from human telomerase reverse transcriptase. Journal of Biological Chemistry, 292 (3). pp. 802-813
• Minoda Y, Virshup I, Rojas I, Haigh O, Wong Y, Miles J, Wells C and Radford K (2017) Human CD141(+) dendritic cell and CD1c(+) dendritic cell undergo concordant early genetic programming after activation in humanized mice in vivo. Frontiers in Immunology, 8.
• Panagides N, Jackson T, Ikonomopoulou M, Arbuckle K, Pretzler R, Yang D, Ali S, Koludarov I, Dobson J, Sanker B, Asselin A, Santana R, Hendrikx I, van der Ploeg H, Tai-A-Pin J, van den Bergh R, Kerkkamp H, Vonk F, Naude A, Strydom M, Jacobsz L, Dunstan N, Jaeger M, Hodgson W, Miles J and Fry B (2017) How the cobra got its flesh-eating venom: cytotoxicity as a defensive innovation and its co-evolution with hooding, aposematic marking, and spitting. Toxins, 9 (3).
• Smallwood T, Giacomin P, Loukas A, Mulvenna J, Clark R and Miles J (2017) Helminth immunomodulation in autoimmune disease. Frontiers in Immunology, 8.
• Blake S, Dougall W, Miles J, Teng M and Smyth M (2016) Molecular pathways: targeting CD96 and TIGIT for cancer immunotherapy. Clinical Cancer Research, 22 (21). pp. 5183-5188
• Blake S, Stannard K, Liu J, Allen S, Yong M, Mittal D, Aguilera A, Miles J, Lutzky V, Ferrari de Andrade L, Martinet L, Colonna M, Takeda K, Kühnel F, Gurlevik E, Bernhardt G, Teng M and Smyth M (2016) Suppression of metastases using a new lymphocyte checkpoint target for cancer immunotherapy. Cancer Discovery, 6 (4). pp. 446-459
• Cole D, Bulek A, Dolton G, Schauenberg A, Szomolay B, Rittase W, Trimby A, Jothikumar P, Fuller A, Skowera A, Rossjohn J, Zhu C, Miles J, Peakman M, Wooldridge L, Rizkallah P and Sewell A (2016) Hotspot autoimmune T cell receptor binding underlies pathogen and insulin peptide cross-reactivity. Journal of Clinical Investigation, 126 (6). pp. 2191-2204
• Dasari V, Schuessler A, Smith C, Wong Y, Miles J, Smyth M, Ambalathingal G, Francis R, Campbell S, Chambers D and Khanna R (2016) Prophylactic and therapeutic adenoviral vector-based multivirus-specific T-cell immunotherapy for transplant patients. Molecular Therapy: methods & clinical development, 3. pp. 1-9
• Karunarathne D, Horne-Debets J, Huang J, Faleiro R, Leow C, Amante F, Watkins T, Miles J, Dwyer P, Stacey K, Yarski M, Poh C, Lee J, Cooper M, Rénia L, Richard D, McCarthy J, Sharpe A and Wykes M (2016) Programmed death-1 ligand 2-mediated regulation of the PD-L1 to PD-1 axis is essential for establishing CD4⁺ T cell immunity. Immunity, 45 (2). pp. 333-345
• Laugel B, Lloyd A, Meermeier E, Crowther M, Connor T, Dolton G, Miles J, Burrows S, Gold M, Lewinsohn D and Sewell A (2016) Engineering of isogenic cells deficient for MR1 with a CRISPR/Cas9 lentiviral system: tools to study microbial antigen processing and presentation to human MR1-restricted T cells. Journal of Immunology, 197 (3). pp. 971-982
• Nguyen T, Bird N, Grant E, Miles J, Thomas P, Kotsimbos T, Mifsud N and Kedzierska K (2016) Maintenance of the EBV-specific CD8+ TCRαβ repertoire in immunosuppressed lung transplant recipients. Immunology and Cell Biology, 95. pp. 77-86

More

ResearchOnline@JCU stores 86+ research outputs authored by A/Prof John Miles from 2003 onwards.

Current and recent Research Funding to JCU is shown by funding source and project.

Advisory Accreditation: I can be on your Advisory Panel as a Primary or Secondary Advisor.

These Higher Degree Research projects are either current or by students who have completed their studies within the past 5 years at JCU. Linked titles show theses available within ResearchOnline@JCU.

Current

• Deconstructing the Immunopathogenesis of Pathogenic Lung Infections (PhD , Primary Advisor/AM)
• First aid of tropical jellyfish stings (PhD , Advisor Mentor)
• High-Throughput and High-Definition Breakdown of Human T Cell Repertoires in Health and Disease (PhD , Primary Advisor/AM)

The map shows research collaborations by institution from the past 7 years.
Note: Map points are indicative of the countries or states that institutions are associated with.